{"url":"https://lda.senate.gov/api/v1/filings/a60de949-ef8d-4e6e-b3e5-6ea33484cb39/","filing_uuid":"a60de949-ef8d-4e6e-b3e5-6ea33484cb39","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2022,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a60de949-ef8d-4e6e-b3e5-6ea33484cb39/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Richard M. Gold, Partner","dt_posted":"2022-04-12T08:25:35-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 17th Street, NW, Suite 1100","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":18466,"url":"https://lda.senate.gov/api/v1/registrants/18466/","house_registrant_id":30825,"name":"HOLLAND & KNIGHT LLP","description":"Law Firm","address_1":"800 17th Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"RICHARD GOLD","contact_telephone":"+1 202-955-3000","dt_updated":"2026-07-30T20:48:41.410941-04:00"},"client":{"id":125214,"url":"https://lda.senate.gov/api/v1/clients/125214/","client_id":1005650,"name":"UNITED MITOCHONDRIAL DISEASE FOUNDATION","general_description":"Non-profit organization","client_government_entity":false,"client_self_select":false,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-02-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"FY2022 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65579,"prefix":null,"prefix_display":null,"first_name":"ETHAN","nickname":null,"middle_name":null,"last_name":"JORGENSEN-EARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58154,"prefix":null,"prefix_display":null,"first_name":"MIRANDA","nickname":null,"middle_name":null,"last_name":"FRANCO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"FY2022 appropriations for the Department of Defense peer reviewed medical research program and Department of HHS, National Institutes of Health Office of the Director (both for mitochondrial disease research).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65579,"prefix":null,"prefix_display":null,"first_name":"ETHAN","nickname":null,"middle_name":null,"last_name":"JORGENSEN-EARP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58154,"prefix":null,"prefix_display":null,"first_name":"MIRANDA","nickname":null,"middle_name":null,"last_name":"FRANCO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}